Zobrazeno 1 - 10
of 73
pro vyhledávání: '"J C, Ouallet"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Ciron, A. Gueguen, A. Al Khedr, B. Bourre, P. Clavelou, G. Defer, F. Durand-Dubief, P. Labauge, J.-C. Ouallet, S. Pittion Vouyovitch, A. Tourbah, P. Vermersch
Publikováno v:
Revue neurologique. 178(10)
In clinical practice, the diagnosis of secondary progressive multiple sclerosis (SPMS) is often delayed, retrospective and non-reproducible, as there are no consensus criteria that define the advent of SPMS. Early identification of SPMS is essential
Autor:
J.-C. Ouallet
Publikováno v:
Revue Neurologique. 176:500-504
Very recent data from cohorts, such as that of the French Observatory of Multiple Sclerosis (OFSEP) and the MSBase cohort, are the subject of new statistical analyses using propensity scores that enable the matching of relapses frequency, EDSS, age,
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C. Donzé, C. Papeix, C. Lebrun-Frenay, C. Lebrun-Frénay, N. Collongues, M. de Seze, A. Dinh, A. Even, C. Scheiber-Nogueira, C. Bensa, B. Bourre, C. Carra-Dallière, J. Ciron, M. Cohen, A.M. Guennoc, C. Louapre, F. Lebreton, L. Michel, E. Maillart, B. Audoin, X. Ayrignac, P. Bernady, B. Brochet, P. Clavelou, R. Colamarino, A. Declemy, J. de Seze, N. Derache, J.-M. Faucheux, O. Heinzlef, P. Labauge, D. Laplaud, E. Lepage, E. Leray, L. Magy, G. Mathey, C. Mekies, V. Mondain, E. Planque, J. Pelletier, S. Pittion, B. Stankhof, P. Tournaire, E. Thouvenot, S. Vukusic, S. Wiertlevski, H. Zephir, H. Alchaar, G. Androdias, M. Benazet, D. Bensmail, D. Biotti, A. Blanchard-Dauphin, M. Bonnan, C. Boutière, P. Branger, S. Bresch, J.-P. Bru, J.-P. Camdessanché, E. Castel Canal, M. Coustans, O. Casez, B. Castan, A. Creange, E. Creisson, T. De Broucker, R. Depaz, X. Douay, C. Dulau, F. Durand-Dubief, O. Fagniez, M. Faucher, A. Floch, M. Fournier, A. Fromont, P. Gallien, X. Gamé, D. Gault, A. Gayou, M. Giroux, O. Gout, J. Grimaud, P. Hautecoeur, A. Kerbrat, L. Kremer, A. Kwiatkowski, C. Labeyrie, S. Lachaud, C. Lanctin-Garcia, L. Lanotte, E. Manchon, A. Maurousset, A.-M. Milor, X. Moisset, A. Mont-Cuquet, T. Moreau, J.-C. Ouallet, I. Patry, D. Peaureaux, M.-C. Pouget, V. Pourcher Martinez, C. Radot, A. Ruet, C. Saint-Val, A. Salmon, F. Taithe, P. Tatevin, M. Vaillant, J.-P. Stahl, F. Vuoto, C. Zaenker
Publikováno v:
Revue Neurologique
Revue Neurologique, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩
Revue Neurologique, Elsevier Masson, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩
Revue Neurologique, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩
Revue Neurologique, Elsevier Masson, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩
Objectives Establish recommendations for the management of UTIs in MS patients. Background Urinary tract infections (UTIs) are common during multiple sclerosis (MS) and are one of the most common comorbidities potentially responsible for deaths from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a5dfd3e0390728753246cc4048803eb
https://hal.umontpellier.fr/hal-03339824
https://hal.umontpellier.fr/hal-03339824
Autor:
C. Lebrun, S. Vukusic, V. Abadie, C. Achour, F. Ader, H. Alchaar, A. Alkhedr, F. Andreux, G. Androdias, R. Arjmand, B. Audoin, D. Audry, D. Aufauvre, C. Autreaux, X. Ayrignac, M. Bailbe, M. Benazet, C. Bensa, D. Bensmail, E. Berger, P. Bernady, Y. Bertagna, D. Biotti, A. Blanchard-Dauphin, J. Bonenfant, M. Bonnan, B. Bonnemain, F. Borgel, E. Botelho-Nevers, S. Boucly, B. Bourre, C. Boutière, P. Branger, D. Brassat, S. Bresch, V. Breuil, B. Brochet, H. Brugeilles, P. Bugnon, P. Cabre, J.-P. Camdessanché, C. Carra-Dalière, O. Casez, J.-M. Chamouard, B. Chassande, P. Chataignier, M. Chbicheb, A. Chenet, J. Ciron, P. Clavelou, M. Cohen, R. Colamarino, N. Collongues, I. Coman, P.-R. Corail, S. Courtois, M. Coustans, A. Creange, E. Creisson, N. Daluzeau, C. Davenas, J. De Seze, M. Debouverie, R. Depaz, N. Derache, L. Divio, X. Douay, C. Dulau, F. Durand-Dubief, G. Edan, Z. Elias, O. Fagniez, M. Faucher, J.-M. Faucheux, M. Fournier, A. Gagneux-Brunon, P. Gaida, P. Galli, P. Gallien, J. Gaudelus, D. Gault, A. Gayou, M. Genevray, A. Gentil, J. Gere, L. Gignoux, M. Giroux, P. Givron, O. Gout, J. Grimaud, A.-M. Guennoc, N. Hadhoum, P. Hautecoeur, O. Heinzlef, M. Jaeger, S. Jeannin, L. Kremer, A. Kwiatkowski, P. Labauge, C. Labeyrie, S. Lachaud, I. Laffont, C. Lanctin-Garcia, J. Lannoy, L. Lanotte, D. Laplaud, D. Latombe, M. Lauxerois, E. Le Page, C. Lebrun-Frenay, P. Lejeune, P. Lejoyeux, B. Lemonnier, E. Leray, C.-M. Loche, C. Louapre, C. Lubetzki, A. Maarouf, B. Mada, L. Magy, E. Maillart, E. Manchon, R. Marignier, P. Marque, G. Mathey, A. Maurousset, C. Mekies, M. Merienne, L. Michel, A.-M. Milor, X. Moisset, A. Montcuquet, T. Moreau, N. Morel, M. Moussa, J.-P. Naudillon, M. Normand, P. Olive, J.-C. Ouallet, O. Outteryck, C. Pacault, C. Papeix, I. Patry, D. Peaureaux, J. Pelletier, B. Pichon, S. Pittion, E. Planque, M.-C. Pouget, V. Pourcher, C. Radot, I. Robert, F. Rocher, A. Ruet, C. Saint-Val, J.-Y. Salle, A. Salmon, E. Sartori, S. Schaeffer, B. Stankhof, F. Taithe, E. Thouvenot, C. Tizon, A. Tourbah, P. Tourniaire, M. Vaillant, P. Vermersch, S. Vidil, A. Wahab, M.-H. Warter, S. Wiertlewski, B. Wiplosz, B. Wittwer, C. Zaenker, H. Zephir
Publikováno v:
Revue Neurologique
Revue Neurologique, Elsevier Masson, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Revue Neurologique, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Revue Neurologique, Elsevier Masson, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Revue Neurologique, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Objectives To establish recommendations on immunization for patients with multiple sclerosis (MS). Background Vaccines have been suspected in the past to trigger MS and relapses. With the extension of the immunoactive treatment arsenal, other concern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4224df57b3ca0c4e2cc01130cb05e47
https://hal.ehesp.fr/hal-02546158
https://hal.ehesp.fr/hal-02546158
Autor:
J. C. Ouallet
Publikováno v:
Emergencies in Neurology ISBN: 9789811373794
Acute demyelinating emergencies usually refer to acute idiopathic inflammatory diseases with white matter involvement of the central nervous system (CNS). Inflammatory demyelinating diseases of the CNS occur worldwide and are the leading cause of non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::431c2c388c48003071627081e15692ba
https://doi.org/10.1007/978-981-13-7381-7_3
https://doi.org/10.1007/978-981-13-7381-7_3
Autor:
Bertrand Audoin, Jean-Philippe Neau, Hélène Zéphir, Raphaël Bernard-Valnet, Sophie Pittion, Romain Marignier, Christine Lebrun, Sandrine Wiertlewski, Bertrand Bourre, David Brassat, Pierre Clavelou, Jonathan Ciron, J.-C. Ouallet, Olivier Outteryck
Publikováno v:
Journal of Neurology. 262:2329-2335
Neuromyelitis optica (NMO) is a life-threatening disease without any validated treatment strategy. Recent retrospective studies suggested the efficacy of B cell depletion without any distinction between first-line or rescue therapy. To assess whether
Autor:
Bruno Brochet, Christine Lebrun-Frénay, Jérôme de Sèze, Hélène Zéphir, E. Allart, B. Audoin, X. Ayrignac, C. Bensa, A. Blanchard-Dauphin, D. Brassat, C. Carra-Dallière, P. Clavelou, M. Cohen, A. Créange, N. Collongues, M. Debouverie, G. Defer, M. de Sèze, C. Donzé, G. Edan, A. Fromont, X. Gamé, O. Gout, C. Guillon, C. Harand, B. Jenny, P. Labauge, P.-H. Lalive, E. Le Page, P. Marque, L. Michel, X. Moisset, J.-C. Ouallet, O. Outteryck, F. Pelé, J. Pelletier, S. Pittion-Vouyovitch, A.-L. Ramelli, A. Ruet, E. Thouvenot, D. Veillard, C. Vignal-Clermont, S. Vukusic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e3fc7b9c7ff155e3474ea7ba89f1506
https://doi.org/10.1016/b978-2-294-75020-5.00002-8
https://doi.org/10.1016/b978-2-294-75020-5.00002-8
Autor:
Hélène Zéphir, David Brassat, E. Bodiguel, David-Axel Laplaud, J. de Seze, C. Bensa, J.-C. Ouallet, E. Le Page
Publikováno v:
Revue Neurologique. 170:247-265
The question of pregnancy in patients with multiple sclerosis is regularly raised due to the prevalence of the disease in middle age women. The multiple sclerosis think tank (Groupe de Réflexion sur la Sclérose en Plaques [GRESEP]) decided to devel